Prescription Drug Abuse as a Public Health Problem in Ohio: A Case Report

Public Health Nursing

Volumn 29, Issue 6, 2012, Pages 553-562

  Winstanley, Erin L ^a   Gay, Joe ^b   Roberts, Lisa ^c   Moseley, Judi ^d   Hall, Orman ^e   Christine Beeghly, B ^d   Winhusen, Theresa ^a   Somoza, Eugene ^a,f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Health Recovery Services   (United States)

^c Portsmouth City Health Department   (United States)

^d OHIO DEPARTMENT OF HEALTH   (United States)

^e Ohio Department of Alcohol and Drug Addiction Services   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Collaboration; Community health nursing; Public health systems; Substance abuse

Indexed keywords

PRESCRIPTION DRUG;

ADDICTION; ARTICLE; COMMUNITY HEALTH NURSING; DRUG OVERDOSE; HUMAN; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; UNITED STATES;

BEHAVIOR, ADDICTIVE; DRUG OVERDOSE; HUMANS; OHIO; PRESCRIPTION DRUGS; PUBLIC HEALTH; PUBLIC HEALTH NURSING; SUBSTANCE-RELATED DISORDERS;

EID: 84867899688     PISSN: 07371209     EISSN: 15251446     Source Type: Journal    
DOI: 10.1111/j.1525-1446.2012.01043.x     Document Type: Article

References (40)

1. Albert, S., Brason, F. W., Sanford, C. K., Dasgupta, N., Graham, J., & Lovette, B. (2011). Project Lazarus: Community-based overdose prevention in rural North Carolina. Pain Medicine, 12, S77-S85.
2. Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010). Preventing opiate overdose deaths: Examining objections to take-home naloxone. Journal of Health Care for the Poor and Underserved, 21(4), 1108-1113.
3. Bennett, A. S., Bell, A., Tomedi, L., Hulsey, E. G., & Kral, A. H. (2011). Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. Journal of Urban Health, 88(6), 1020-1030.
4. Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002). Improving primary care for patients with chronic illness: The chronic care model, Part 2. JAMA, 288(15), 1909-1914.
5. Centers for Disease Control and Prevention. (2011a). Community-based opioid prevention programs proving Naloxone - United States, 2010. Morbidity and Mortality Weekly Report, 61(6), 101-105.
6. Centers for Disease Control and Prevention. (2011b).Prescription Painkiller Overdoses in the US (Vital signs November 2011). Retrieved from http://www.cdc.gov/vitalsigns/PainkillerOverdoses/index.html
7. Clark, R. E., Samnaliev, M., Baxter, J. D., & Leung, G. Y. (2011). The evidence doesn't' justify steps by state medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Affairs, 30(8), 1425-1431.
8. Compton, W. M., & Volkow, N. D. (2006). Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence, 83S, S4-S7.
9. De Wit, J. B. F., Das, E., & Vet, R. (2008). What works best: Objective statistics or personal testimonial? An assessment of the persuasive effects of different types of message evidence on risk perception. Health Psychology, 27(1), 110-115.
10. Ducharme, L. D., & Abraham, A. J. (2008). State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse, Treatment, and Prevention Policy, 3, 17.
11. Ducharme, L. J., & Roman, P. M. (2009). Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. Journal of Substance Abuse Treatment, 37, 90-94.
12. Executive Office of the President of the United States. (2011). Epidemic: Responding to America's prescription drug abuse crisis. Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf
13. Hemingway, S. (2011). Reforms aim to stem opiate abuse in Vermont. Burlington Free Press. Retrieved from http://www.burlingtonfreepress.com
14. Holmes, D. (2011). Prescription drug addiction: The treatment challenge. The Lancet, 379, 17-18.
15. Horgan, C. M., Reif, S., Hodgkin, D., Garnick, D. W., & Merrick, E. L. (2008). Availability of addiction medications in private health plans. Journal of Substance Abuse Treatment, 34, 147-156.
16. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2010). Monitoring the Future, National results on adolescent drug use: Overview of key findings, 2009 (NIH Publication No. 10-7583). Retrieved from http://monitoringthefuture.org/pubs/monographs/overview2009.pdf
17. Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., et al. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine, 352(24), 2515-2523.
18. Knudsen, H. K., Abraham, A. J., & Roman, P. M. (2011). Adoption and implementation of medications in addiction treatment programs. Journal of Addiction Medicine, 5(1), 21-27.
19. Kresina, T. F., & Lubran, R. (2011). Improving public health through access to and utilization of medication assisted treatment. International Journal of Environmental Research and Public Health, 8, 4102-4117.
20. Kuehn, B. M. (2007). Prescription drug abuse rises globally. JAMA 297(2), 1306.
21. National Institute of Medicine. (2006). Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: National Academies Press.
22. Ohio Department of Health, Violence and Injury Prevention Program. (2011a). 2010 Ohio drug overdose data: General findings. Retrieved from http://www.odh.ohio.gov/sitecore/content/HealthyOhio/default/vipp/drug/~/media/E0E9AA2C0FD14B7F941F1EE05BDB3924.ashx
23. Ohio Department of Health, Violence and Injury Prevention Program. (2011b). Epidemic of prescription drug overdose in Ohio. Retrieved from http://www.healthyohioprogram.org/~/media/HealthyOhio/ASSETS/Files/injury%20prevention/ohiodrugpoisoningfactsheet.ashx
24. Paulozzi, L., Baldwin, G., Franklin, G., Kerlikowske, R. G., Jones, C. M., Ghiya, N., et al. (2012). CDC grand rounds: Prescription drug overdoses - a U.S. epidemic. MMWK Morbidity and Mortality Weekly Report, 61(1), 10-13.
25. Starr, S., Sherba, R. T., Massatti, R., Patel, T. P., Adhikari, S. B., Potts, L., et al. (2011). Ohio Department of Alcohol and Drug Addiction Services Prescription Drug/Opioid Abuse Survey November 2010. Retrieved from http://www.odadas.state.oh.us/public/OpenFile.aspx?DocumentID = 9962178d-fa0e-444b-b5cb-8990116f97c4
26. Thomas, C. P., Garnick, D. W., Horgan, C. M., McCorry, A., Chalk, M., Gastfriend, D. R., et al. (2011). Advancing performance measures for use of medication in substance abuse treatment. Journal of Substance Abuse Treatment, 40, 35-43.
27. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services, Administration Office of Applied Studies. (2010a). 2009 State profile - Ohio national survey of substance abuse treatment services (N-SSATS). Retrieved from http://wwwdasis.samhsa.gov/webt/state_data/OH09.pdf
28. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services, Administration Office of Applied Studies. (2010b). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (NSDUH Series H-38A, HHS Publication No. SMA 10-4856Findings). Rockville, MD: Office of Applied Studies.
29. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services, Administration Office of Applied Studies. (2011). 2010 State profile - United States national survey of substance abuse treatment services (N-SSATS). Retrieved from http://wwwdasis.samhsa.gov/webt/state_data/US10.pdf
30. U.S. Drug Enforcement Agency. (2011). Jury convicts physician of illegally prescribing pills that led to deaths of four people (News Release). Retrieved from http://www.justice.gov/dea/pubs/states/newsrel/2011/detroit051011.html
31. U.S. Drug Enforcement Agency. (2012). Current Drug Shortages. Retrieved from http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm
32. U.S. Government Accountability Office. (2011). Prescription pain reliever abuse: Agencies have begun coordinating education efforts, but need assess effectiveness (Highlights of GAO-12-115). Retrieved from http://www.gao.gov/assets/590/587300.pdf
33. Vastag, B. (2001). Mixed message on prescription drug abuse. JAMA, 285(17), 2183-2184.
34. Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30, 155-166.
35. Walley, A. Y., Alperen, J. K., Cheng, D. M., Botticelli, M., Castro-Donlan, C., Samet, J. H., et al. (2008). Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine, 23(9), 1393-1398.
36. Warner, M., Chen, L., Makuc, D., Anderson, R. N., & Minino, A. M. (2011). Drug poisoning deaths in the United States, 1980-2008 (NCHS data brief, no 81). Retrieved from http://www.cdc.gov/nchs/data/databriefs/db81.pdf
37. Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., et al. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence. Archives of General Psychiatry, 68(12), 1238-1246.
38. West, J. C., Kosten, T. R., Wilk, J., Dvikis, D., Triffleman, E., Rae, D. S., et al. (2004). Challenges in increasing access to buprenorphine treatment for opiate addiction. The American Journal on Addictions, 13, S8-S16.
39. Winstanley, E. L., Fishman, M., & Bolon, S. K. (2010).Chapter 46, Treatment Outcomes for Addiction. In N. S. Miller & M. S. Gold (Eds.), Addictions in Medicine: Principles and practices. West Sussex, UK: Wiley Inc.
40. Winstanley, E. L., Steinwachs, D. M., Ensminger, M. E., Latkin, C. A., Stitzer, M. L., & Olsen, Y. (2007). The association of neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug and Alcohol Dependence, 92(1-3), 173-182.